Sell Dyax on buyout offer
[from today’s edition of Smart Tech 50 Weekly Movers]
Dyax Corp. (DYAX) received a $5.9 billion dollar buyout offer from Shire Pharmaceuticals. The stock, early on Monday morning (11/2/15) was trading above $36 per share, a nearly 33% premium over the 10/30/15 closing price. We recommend sale of the shares for reasons explained in the full article.